Our Cancer Team
Our oncology services team consists of board-certified physicians and specially trained oncology nurses who are here to help you in all phases of cancer care. Whether you’re undergoing screenings, diagnosis, treatment or ongoing care, we are dedicated
to making your cancer journey easier. We even have an experienced Oncology Patient Navigator on staff to provide extra support for patients, families and caregivers.
Medical Director of Medical Oncology
Mahdi Taha, DO, FACOI, FACP, Board Certified Medical Oncologist, Medical Director of Medical Oncology.
Dr. Taha specializes in Head and Neck Cancers including Oropharynx, Nasopharynx, Hypopharynx, Salivary Gland Carcinomas and Thyroid. He also specializes in Skin Cancers including Melanoma, Basal Cell Carcinoma, Squamous Cell Carcinoma and Genitourinary
Carcinomas including Prostate, Bladder, Renal Pelvis, Testicular and Renal Cell.
As Medical Director of Medical Oncology for Palm Beach Health Network, Dr. Taha works in collaboration with medical peers, colleagues and hospital leadership - serving as a liaison to medical staff committees; identifying current and future technology requirements;
advising on the modifications of existing programs and the development of new programs or services; and establishing methods to improve overall efficiency. He also develops medical education programs for the medical staff, nursing and ancillary personnel
of the hospital.
Prior to joining Palm Beach Health Network, Dr. Taha worked for Cancer Treatment Centers of America (CTCA) in Newnan, Georgia, as the Lead Medical Oncologist for Head and Neck, Genitourinary, Melanoma and Salivary Gland Carcinomas. He also served as CTCA’s
Vice President of Quality Chairman. Prior to that role, he was an Adjunct Clinical Professor at Morehouse School of Medicine. Dr. Taha completed an observership in Genitourinary Oncology and Head and Neck Thoracic Oncology at MD Andersen.
Dr. Taha earned his medical degree from New York College of Osteopathic Medicine. After completing his residency in Internal Medicine at the Oklahoma State University Medical Center in Tulsa, OK, he was awarded a Fellowship at Cancer Treatment Centers
of America through Oklahoma State University, where he was named Medical Oncology Chief Fellow. He received his received his Bachelor of Arts in Biology from Kean University, where he graduated Magna Cum Laude.
Dr. Taha is a Fellow of the American College of Osteopathic Internists (2016), a Fellow of the American College of Physicians (2018), a 2017 Castle and Connelly Atlanta Top Doctor-Oncologist Award Recipient, a 2019 Castle and Connelly Atlanta Top Doctor-Oncologist
Award Recipient and a 2019 Georgia Trend Magazine “Top 40 Under 40” Recipient.
Dr. Taha has a strong interest in research with a focus in Genitourinary Carcinomas including Prostate, Renal Cell, Bladder and Testicular; and Head and Neck, Melanoma and Lung Cancers. He has served on various research committees and participated as
principal investigator during several clinical trial studies. Dr. Taha has given presentations at conferences including the ACOI National Convention Case Presentation in San Antonio, Texas, which won the First Place National Award, and serves as a
medical consultant for Eisai Pharmaceuticals, Novartis Pharmaceuticals, CBS – “Atlanta Plugged In,” Genentech BioOncology and Merck Pharmaceutical Inc.
Dr. Taha is affiliated with Florida Cancer Specialists. His office will be located at 5130 Linton Blvd Suite B-4, in Delray Beach.